FIELD: medicine.
SUBSTANCE: blood is examined. The steroid hormones cortisol (nmole/l) and DHEA-S (mcmole/l), as well as the oxidative stress values - oxidative modified proteins (OMP, nM/mg, protein), malondialdehyde (MDA, nM/ml) and SH groups mg% are evaluated. The forced expiratory volume 1(%) FEV1 is calculated by formula on the basis of the derived values. If the derived FEV1 is within 50% to 80%, the presence of a moderate degree of chronic obstructive pulmonary disease; the FEV1 being within the range of 30 to 49% means a severe degree of chronic obstructive pulmonary disease (COPD), and the derived value being less than 30% shows an extremely severe degree of COPD.
EFFECT: reliable determination of a degree of severity of chronic obstructive pulmonary disease.
3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EVALUATING THE UNFAVORABLE COURSE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION WHEN COMBINED | 2018 |
|
RU2711453C1 |
METHOD OF TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2016 |
|
RU2609274C1 |
METHOD FOR IMPROVEMENT OF SPUTUM EXPECTORATION | 2016 |
|
RU2609992C1 |
METHOD OF PREDICTING FREQUENCY OF EXACERBATIONS OF CHRONIC OBSTRUCTIVE LUNG DISEASE | 2011 |
|
RU2484770C2 |
METHOD FOR IMPROVING QUALITY OF LIFE AND PROLONGING REMISSION PERIOD IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2014 |
|
RU2576837C1 |
METHOD OF TREATING PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ISCHEMIC HEART DISEASE WITH CARDIAC FAILURE COMPLICATED WITH ANAEMIA | 2012 |
|
RU2485960C1 |
METHOD FOR DETERMINING DEGREE OF SEVERITY OF AGGRAVATED CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) FOR SPECIFYING OPTIMAL APPROACH TO PATIENT MANAGEMENT | 2011 |
|
RU2467685C2 |
METHOD FOR PREDICTION OF INFECTIOUS COMPLICATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2015 |
|
RU2595853C1 |
METHOD FOR PREDICTING RECRUDESCENCE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN PATIENTS WITH INSOMNIA | 2018 |
|
RU2681272C1 |
METHOD OF TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2015 |
|
RU2600833C1 |
Authors
Dates
2014-05-20—Published
2012-12-24—Filed